Molecular cardiology: The Molecular Cardiology involves the study of the molecular mechanisms of cardiovascular biology and human cardiovascular diseases. It focuses on discovering novel pathways that modulate cardiac hypertrophy, aging and metabolic diseases with specific attention to interpreting bench findings to new bedside approaches and strategies.
Cellular cardiology: Heart failure is the chief cause of mortality worldwide. Cardiac remodeling is the adaptive mechanism that causes ventricular dysfunction. In present article the authors explain the elements of the human heart and their examination of basic functions and their inter-communication under both normal and pathological circumstances.
Important Alert:
X
Title : Antiplatelet agents as a novel therapy of heart failure due to myocardial infarction
Naranjan S Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada
Title : System methods to define master regulator of cell identity in development and diseases
Kaifu Chen, Boston Children’s Hospital, United States
Title : Advanced molecular and cellular mechanisms for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Protecting cardiac potassium channels as a novel strategy to prevent ischemia-associated arrhythmias and sudden cardiac death
Shetuan Zhang, Queen’s University, Canada
Title : Autoimmunity to GRP78 is associated with atherosclerosis in COPD patients, and a pilot trial of autoimmune therapy with belimumab
Duncan Steven R, University of Alabama at Birmingham, United States
Title : Complementing echocardiography: diagnosing heart failure and valve disease on patient presentation at point of care
Marc Bisnaire, Cardio-Phoenix Ltd, United Kingdom